|PLATO North American Substudy & First in Man Vascular Graft Breaking News|
Free Archived Webinar:
- First Human Use of an Allogeneic Tissue Engineered Vascular Graft
Description: A first-in-human study to test the feasibility of an allogeneic tissue-engineered vascular graft
Presenter: Todd N. McAllister, Novato, Calif.
View abstract | Science News
- Ticagrelor Compared with Clopidogrel by Geographic Region in the Platelet Inhibition and Patient Outcomes (PLATO) Trial
Description: Presentation of the regional variation in outcomes in PLATO with an emphasis on the North American cohort
Presenter: Kenneth W. Mahaffey, Durham, N.C.
View abstract | View manuscript | Science News
About the Series | Learning Objectives | CME/CE Credit | Submission Guidelines (PDF)
Beginning in 2011, the AHA is giving you an opportunity to present your best science through the new Emerging ScienceTM Series. The new online event will feature a free webinar presentation of cutting-edge science. This live, moderated event and online forum will have submission opportunities for late-breaking clinical trials, key updates of previously presented trials, late-breaking basic science and more, as well as a discussion forum for Q&A. This forum offers submission opportunities in the following areas:
View ESS Brochure
- Late-breaking clinical trials
- Key updates of previously presented trials
- Late-breaking science, new analyses or substudies, and more
- Major bench-to-bedside breakthroughs
- Publication of the abstract in Circulation: Journal of the American Heart Association
- Guaranteed fast-track review of a manuscript for one of the AHA journals (fast-track review does not guarantee ultimate publication in a journal)
- Late-breaking clinical trials will have a guaranteed presentation time in a “Clinical Trial Update Session” at Scientific Sessions 2011
About the Series
The AHA recognizes important scientific results do not always conveniently coincide with the timing of AHA Scientific Sessions in November. The AHA Emerging ScienceTM Series will be one-hour professional quality webinars held two or three times per year. Each session will have two 30-minute blocks consisting of presentations of original research from the following categories: late breaking clinical trials, clinical trial updates of previously presented LBCTs and late breaking basic science. A steering committee will make the final selection from the reviewers’ comments and decide whether to present material from one of the following additional categories: major bench-to-bedside advances, major conference proceedings and major guidelines/policy statements. The live webinars will be viewable from a computer or mobile phone. The series will be archived for on-demand viewing. A panel of moderators and discussants will spend more time than allows at November’s Scientific Sessions for discussion and questions. Attendees can ask questions electronically during or after the event.
After completing these programs, participants will be able to:
- Assess the quality of the clinical trials and data presented during the sessions, including endpoints, size of the trial, outcomes and adverse events
- Discuss the potential effects of the data presented on clinical practice
- Identify opportunities, if appropriate, for integrating the findings presented into clinical practice
- Improve their adherence to cardiovascular and stroke-related guidelines
Continuing Medical Education Accreditation - Physicians
The American Heart Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Heart Association designates this educational activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. All faculty participating in CME/CE activities sponsored by The American Heart Association will disclose to the audience (1) significant financial relationships with the manufacturer(s) of products from the commercial supporter(s) and/or the manufacturer(s) of products or devices discussed in their presentation, and (2) unlabeled/unapproved uses of drugs or devices discussed in their presentation. Such disclosures will be made in writing in course presentation materials.
Continuing Medical Education Accreditation – Physician Assistants
AAPA accepts Category I credit from AOACCME, Prescribed credit from AAFP, and AMA PRA Category 1 Credit™ from organizations accredited by ACCME.
Continuing Education Accreditation - Nurses
American Heart Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. The maximum number of hours awarded for this CE activity is 1.00 contact hour. Accredited status does not imply endorsement by the American Heart Association or the American Nurses Credentialing Center of any commercial products displayed in conjunction with an activity.
Continuing Education Accreditation – Pharmacists
The American Heart Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Credit: 1.00 Contact Hour or 0.100 CEUs. Universal Program Number: 0256-0000-11-643-L01-P. Successful completion of this CME activity includes the following: (1) Register. (2) Participate in course. (3) Complete the activity evaluation survey and claim your CME/CE certificate online at learn.heart.org. There is no fee for CME/CE credits for this activity.
Release date and last review: June, 2011
Expiration date: June, 2014